Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pearl Therapeutics has completed the closing of an $18 million round of financing. This financing was executed as an extension to its first venture financing, which closed in May 2007.
Subscribe to our email newsletter
Participating in the internal round were Pearl’s existing investors Clarus Ventures, New Leaf Ventures, 5AM Ventures and Nektar Therapeutics. In total, Pearl has raised $36.4 million of venture and other funding.
Adrian Smith, president, and co-founder of Pearl, said: “This follow-on financing signifies the confidence and enthusiasm of our investors, and we are delighted with their continued support. This additional capital will allow us to broaden and progress development efforts on our products and delivery platform.”